- Home
- ADXN vs NLSP Comparison
ADXN vs NLSP Comparison
Compare ADXN & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- NLSP
- Stock Information
- Founded
- ADXN 2002
- NLSP 2015
- Country
- ADXN Switzerland
- NLSP Switzerland
- Employees
- ADXN N/A
- NLSP N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- NLSP Health Care
- Exchange
- ADXN Nasdaq
- NLSP Nasdaq
- Market Cap
- ADXN 11.3M
- NLSP 243.8M
- IPO Year
- ADXN N/A
- NLSP 2021
- Fundamental
- Price
- ADXN $10.30
- NLSP $4.55
- Analyst Decision
- ADXN Strong Buy
- NLSP
- Analyst Count
- ADXN 1
- NLSP 0
- Target Price
- ADXN $30.00
- NLSP N/A
- AVG Volume (30 Days)
- ADXN 22.8K
- NLSP 33.1K
- Earning Date
- ADXN 11-11-2024
- NLSP 11-01-2024
- Dividend Yield
- ADXN N/A
- NLSP N/A
- EPS Growth
- ADXN N/A
- NLSP N/A
- EPS
- ADXN 0.05
- NLSP N/A
- Revenue
- ADXN $960,641.00
- NLSP N/A
- Revenue This Year
- ADXN N/A
- NLSP N/A
- Revenue Next Year
- ADXN N/A
- NLSP N/A
- P/E Ratio
- ADXN $1.75
- NLSP N/A
- Revenue Growth
- ADXN N/A
- NLSP N/A
- 52 Week Low
- ADXN $5.00
- NLSP $4.08
- 52 Week High
- ADXN $27.90
- NLSP $29.84
- Technical
- Relative Strength Index (RSI)
- ADXN 54.08
- NLSP 40.59
- Support Level
- ADXN $10.04
- NLSP $4.38
- Resistance Level
- ADXN $10.81
- NLSP $5.64
- Average True Range (ATR)
- ADXN 0.59
- NLSP 0.47
- MACD
- ADXN 0.04
- NLSP 0.06
- Stochastic Oscillator
- ADXN 70.88
- NLSP 29.16
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.